Matches in SemOpenAlex for { <https://semopenalex.org/work/W2910415101> ?p ?o ?g. }
- W2910415101 endingPage "119" @default.
- W2910415101 startingPage "112" @default.
- W2910415101 abstract "The purpose of this study was to investigate indoleamine 2,3-dioxygenase 1 (IDO1) expression and its implications in uveal melanoma (UM). Bioinformatics analysis was performed on microarray data (GSE22138 and GSE27831) from the Gene Expression Omnibus (GEO) database to evaluate IDO1 expression in mRNA level. Ninety-two cases in the database were divided into the IDO1-high group (46 cases) and IDO1-low group (46 cases). Paraffin embedded tumor sections from 27 patients with UM were studied by immunofluorescence. The mRNA results showed that IDO1 expression was inversely correlated with tumor thickness (9.93 ± 3.33 mm in IDO1-high group vs. 11.56 ± 2.38 mm in IDO1-low group) (p = 0.016) and metastatic rate (30.4% in IDO1-high group vs. 69.6% in IDO1-low group, p < 0.001). The IDO1-high group showed higher immune cell gene expression: CD3D (6.56 ± 1.0 vs. 5.46 ± 0.53, p < 0.0001), CD4 (4.72 ± 0.4 vs. 4.2 ± 0.42, p < 0.0001), and CD68 (6.17 ± 1.23 vs. 5.53 ± 0.77, p = 0.015). Further analysis showed that immune-suppressive T regulatory cell genes (CD3D, CD4, IL2RA and FOXP3) were expressed in 67.4% (31/46) cases in the IDO1-high group and 23.91% (11/46) cases in the IDO1-low group. In addition, IDO1 and interferon gamma (IFNG) mRNA expression were strongly correlated (r = 0.70, p < 0.0001). The correlation analysis of different immune checkpoints showed that IDO1 was positively correlated with CD274(PDL1), but not CTLA4 or PDCD1.The disease-free survival (DFS) in the IDO1-high/IFNG-high group was better than that of the IDO1-low/IFNG-low group. The IDO1 immunostaining result showed that 2 cases in 18 UMs with Bruch's membrane (BM) rupture and 7 out of 9 cases without BM rupture were scored high (Grade 2–3) (p = 0.001). Comparing the immune cells staining results between IDO1-high group and IDO1-low group, higher percentage of patients in the former group had high levels of T cells and macrophages infiltration, but only the difference in macrophage was statistically significant (CD68, 77.78% vs. 27.78%, p = 0.04). The analysis based on GEO data and the result from immunostaining study are consistent with each other. In conclusion, the expression of IDO1 is probably induced by IFNγ from infiltrated immune cells in UM. BM rupture is an important indicator of IDO1 expression level and distribution pattern. The complex role of IDO1 may limit its therapeutic effect in UM." @default.
- W2910415101 created "2019-01-25" @default.
- W2910415101 creator A5016528100 @default.
- W2910415101 creator A5021677413 @default.
- W2910415101 creator A5043278257 @default.
- W2910415101 creator A5048295434 @default.
- W2910415101 creator A5051031749 @default.
- W2910415101 creator A5056040210 @default.
- W2910415101 creator A5069318637 @default.
- W2910415101 creator A5083688911 @default.
- W2910415101 creator A5090266617 @default.
- W2910415101 date "2019-04-01" @default.
- W2910415101 modified "2023-10-06" @default.
- W2910415101 title "Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma" @default.
- W2910415101 cites W1503992437 @default.
- W2910415101 cites W1973251492 @default.
- W2910415101 cites W1980046832 @default.
- W2910415101 cites W1999601075 @default.
- W2910415101 cites W2004528113 @default.
- W2910415101 cites W2005576578 @default.
- W2910415101 cites W2030106234 @default.
- W2910415101 cites W2030410453 @default.
- W2910415101 cites W2031087147 @default.
- W2910415101 cites W2043115106 @default.
- W2910415101 cites W2056737202 @default.
- W2910415101 cites W2075094265 @default.
- W2910415101 cites W2078434983 @default.
- W2910415101 cites W2078979790 @default.
- W2910415101 cites W2084823216 @default.
- W2910415101 cites W2093924388 @default.
- W2910415101 cites W2097049582 @default.
- W2910415101 cites W2103553504 @default.
- W2910415101 cites W2104065243 @default.
- W2910415101 cites W2126932404 @default.
- W2910415101 cites W2128035403 @default.
- W2910415101 cites W2133075384 @default.
- W2910415101 cites W2143878396 @default.
- W2910415101 cites W2149398709 @default.
- W2910415101 cites W2152897456 @default.
- W2910415101 cites W2154879572 @default.
- W2910415101 cites W2160360616 @default.
- W2910415101 cites W2217683734 @default.
- W2910415101 cites W2273004055 @default.
- W2910415101 cites W2306053308 @default.
- W2910415101 cites W2342956596 @default.
- W2910415101 cites W2397191612 @default.
- W2910415101 cites W2515516401 @default.
- W2910415101 cites W2557238488 @default.
- W2910415101 cites W2570766240 @default.
- W2910415101 cites W2595109242 @default.
- W2910415101 cites W2604931745 @default.
- W2910415101 cites W2745658163 @default.
- W2910415101 cites W2746164323 @default.
- W2910415101 cites W2786095824 @default.
- W2910415101 cites W2883806089 @default.
- W2910415101 cites W2885298062 @default.
- W2910415101 doi "https://doi.org/10.1016/j.exer.2019.01.005" @default.
- W2910415101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30639792" @default.
- W2910415101 hasPublicationYear "2019" @default.
- W2910415101 type Work @default.
- W2910415101 sameAs 2910415101 @default.
- W2910415101 citedByCount "10" @default.
- W2910415101 countsByYear W29104151012019 @default.
- W2910415101 countsByYear W29104151012020 @default.
- W2910415101 countsByYear W29104151012021 @default.
- W2910415101 countsByYear W29104151012022 @default.
- W2910415101 countsByYear W29104151012023 @default.
- W2910415101 crossrefType "journal-article" @default.
- W2910415101 hasAuthorship W2910415101A5016528100 @default.
- W2910415101 hasAuthorship W2910415101A5021677413 @default.
- W2910415101 hasAuthorship W2910415101A5043278257 @default.
- W2910415101 hasAuthorship W2910415101A5048295434 @default.
- W2910415101 hasAuthorship W2910415101A5051031749 @default.
- W2910415101 hasAuthorship W2910415101A5056040210 @default.
- W2910415101 hasAuthorship W2910415101A5069318637 @default.
- W2910415101 hasAuthorship W2910415101A5083688911 @default.
- W2910415101 hasAuthorship W2910415101A5090266617 @default.
- W2910415101 hasConcept C104317684 @default.
- W2910415101 hasConcept C126322002 @default.
- W2910415101 hasConcept C150194340 @default.
- W2910415101 hasConcept C159654299 @default.
- W2910415101 hasConcept C186836561 @default.
- W2910415101 hasConcept C203014093 @default.
- W2910415101 hasConcept C204232928 @default.
- W2910415101 hasConcept C2776460901 @default.
- W2910415101 hasConcept C2776706248 @default.
- W2910415101 hasConcept C2777658100 @default.
- W2910415101 hasConcept C2778236600 @default.
- W2910415101 hasConcept C2779727006 @default.
- W2910415101 hasConcept C502942594 @default.
- W2910415101 hasConcept C515207424 @default.
- W2910415101 hasConcept C55493867 @default.
- W2910415101 hasConcept C71924100 @default.
- W2910415101 hasConcept C83478079 @default.
- W2910415101 hasConcept C8415881 @default.
- W2910415101 hasConcept C86803240 @default.
- W2910415101 hasConcept C8891405 @default.
- W2910415101 hasConceptScore W2910415101C104317684 @default.